UBS Group
WVE icon

UBS Group’s Wave Life Sciences WVE Stock Holding History

UBS Group’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30,000
Closed -$510K – 11241
2025
Q4 		$510K Buy
+30,000
New +$305K ﹤0.01% 6078

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

UBS Group's WVE Position: Q1 2026 in Review

UBS Group increased its Wave Life Sciences (WVE) stake by 101% in Q1 2026, buying an estimated $3.52M and bringing the position to 538,997 shares worth $3.91M. The position accounts for ﹤0.01% of the portfolio, ranked #4324.

UBS Group first reported a position in WVE in Q4 2015 and has held it in 42 quarters since. The position peaked at $5.17M in Q3 2025. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • UBS Group held 538,997 shares of Wave Life Sciences worth $3.91M as of Q1 2026.
  • UBS Group bought 270,274 Wave Life Sciences shares in Q1 2026, an estimated $3.52M.
  • Wave Life Sciences made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #4324 holding.
  • UBS Group first reported a position in Wave Life Sciences in Q4 2015 and has held it in 42 quarters since.
  • UBS Group's Wave Life Sciences position peaked at $5.17M in Q3 2025.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.